Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.765 USD | +2.04% | +20.57% | +70.66% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 495M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -144M | EV / Sales 2024 * | - |
Net cash position 2024 * | 182M | Net cash position 2025 * | 57.6M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.3
x | P/E ratio 2025 * |
-3.7
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Larimar Therapeutics, Inc.
1 day | +2.04% | ||
1 week | +20.57% | ||
Current month | +12.70% | ||
1 month | +0.58% | ||
3 months | +26.26% | ||
6 months | +143.04% | ||
Current year | +70.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | - | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 20-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-05-27 |
Frank Thomas
BRD | Director/Board Member | 54 | 20-05-27 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 23-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 7.765 | +2.04% | 231,966 |
24-05-02 | 7.61 | +3.54% | 220,416 |
24-05-01 | 7.35 | +6.68% | 388,503 |
24-04-30 | 6.89 | +4.24% | 266,235 |
24-04-29 | 6.61 | +2.64% | 296,313 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.66% | 495M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- LRMR Stock